Social Media Influencers Fueling Parallel Market for Unapproved Slimming Drug
An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with numerous of members share comparison images, injection guides and claims of rapid British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Express Concerns
Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could result in individuals administering products of unknown origin.
Some professionals said the demand for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or imprisonment.
Service Reaction and Content Removal
According to TikTok, the platform has taken down problematic material and prohibited associated hashtags and query recommendations. The organization stated it was committed to keeping the platform safe and investing in strengthening compliance measures.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 members selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at home.
After minutes of entering one community, a vendor posted contact information, where most transactions occur. The seller provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.
Product Information and Pricing
Within these communities, posts display black plastic packages with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When asked how long a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for Telegram said it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has previously encountered individuals injured by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational product not yet approved … may expose patients to possibly significant medical dangers”.
